Deayton J, O'Sullivan E, McKnight A, Groves K, Bibby D, Clark D, Orkin C, Reeves I et al.(2015). Disease progression in HIV-1 controllers; uptake and outcome of antiretroviral therapy. HIV MEDICINE vol. 16, 20-20.
Elamin W, Bibby D, Clark D, Anderson J, Deayton J(2013). HIV-2 in the United Kingdom - the North-East London cohort. HIV MEDICINE vol. 14, 53-53.
Pozniak A, Rackstraw S, Deayton J, Barber T, Taylor S, Manji H, Melvin D, Croston M et al.(2013). HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient sub-groups. Antivir Ther
Groves KC, Bibby DF, Clark DA, Isaksen A, Deayton JR, Anderson J, Orkin C, Stagg AJ et al.(2012). Disease Progression in HIV-1-Infected Viremic Controllers. J Acquir Immune Defic Syndr vol. 61, (4) 407-416.
Peterson K, Ruelle J, Vekemans M, Siegal FP, Deayton JR, Colebunders R(2012). The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series. Antivir Ther vol. 17, (6) 1097-1100.
Groves K, Bibby D, Clark D, Isaksen A, Deayton J, Anderson J, Orkin C, Stagg AJ et al. (2010). Disease Progression Despite Suppressed Plasma Viral Load in Human Immunodeficiency Infected Viremic Controllers. AIDS RESEARCH AND HUMAN RETROVIRUSES. vol. 26, A163-A163.
Dhairyawan R, Hutchinson J, Deayton J, Estcourt C (2010). Educating East London primary care providers to improve rates of HIV testing and HIV recognition in an area of high HIV prevalence and late presentation.
Deayton J, Clark D, Bibby D (2010). HIV-2 viral load testing - validation and quantification at low copy number.
Deayton J, Bibby D, Orkin C, O'Sullivan E, McKnight A, Clark D (2010). Inter-clade dual HIV-1 infection in the UK - an emerging phenomenon.
Hogan S, DeSouza C, Deayton J (2010). Lymphopenia on routine full blood count as an indicator of undiagnosed HIV infection.
Deayton JR, Thorpe JW(2010). Neurological Complications of HIV Infection and AIDS. Treatment Strategies - AIDS vol. The Cambridge Resear, 121-126.
Groves KC, Bibby D, Isaksen A, Deayton J, Anderson J, Orkin C, Stagg AJ, McKnight A(2009). Altered T cell homeostasis and activation in HIV-1 elite suppressors with low CD4+T-cell counts. RETROVIROLOGY vol. 6, Article P250,
Thorpe JW, Deayton JR(2009). Neurological Complications of HIV. Medicine (37) 352-356.
Waters LJ, Dave SS, Deayton JR, French PD(2005). Recalcitrant Trichomonas vaginalis infection--a case series. Int J STD AIDS vol. 16, (7) 505-509.
Deayton JR, Prof Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD(2004). Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet vol. 363, (9427) 2116-2121.
Deayton JR, Sabin CA, Britt WB, Jones IM, Wilson P, Johnson MA, Griffiths PD, Emery VC(2002). Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. AIDS vol. 16, (16) 2129-2135.
Deayton JR(2001). Changing trends in cytomegalovirus disease in HIV-infected patients. Herpes vol. 8, (2) 37-40.
Worrell S, Deayton J, Hayes P, Emery VC, Gotch F, Gazzard B, Larsson-Sciard EL(2001). Molecular correlates in AIDS patients following antiretroviral therapy: diversified T-cell receptor repertoires and in vivo control of cytomegalovirus replication. HIV Med vol. 2, (1) 11-19.
Deayton JR, Sabin CA, Johnson MA, Griffiths PD, Emery VC(2000). Efficacy of the regenerating immune system in the inhibition of CMV replication after highly active antiretroviral therapy (HAART)). AIDS vol. 14, S5-S5.
Deayton JR, Shannon-Lowe C, Wilson P, Johnson MA, Griffiths PD, Emery VC (2000). Recurrence of CMV viraemia and development of anti-CMV drug resistance in patients receiving highly active antiretroviral therapy after CMV retinitis.